2914:TSEJapan Tobacco Inc. Analysis
Data as of 2026-03-10 - not real-time
¥5,743.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Japan Tobacco posted record FY2025 results, with operating margins near 25% and an adjusted operating profit surge of almost 25% YoY, underscoring strong pricing power and successful rollout of reduced‑risk products. Revenue is flat year‑over‑year, but profit expansion and a solid free cash flow generation of over ¥180 bn support the current dividend payout of roughly 4.3%. The stock trades at a PE around 20x and a PB close to 2.5x, while the beta is exceptionally low (well below 0.2), indicating limited price volatility relative to the market. Technical indicators show a bullish overall trend but a bearish MACD and price below the 20‑day SMA suggest short‑term pressure, with the current price sitting comfortably above the identified support of ¥5,551. The upside estimate of about 6½% and a “Extreme Greed” sentiment on the fear‑greed index add a modest bullish bias. However, the company carries a high debt‑to‑equity ratio (~46) and operates in a heavily regulated tobacco sector, which tempers the upside.
Given the attractive dividend yield, solid cash generation, and defensive positioning, the stock appears fairly valued with a slight upside potential. The combination of stable earnings, dividend sustainability, and modest growth from new product lines supports a buy stance for medium‑ to long‑term horizons, while short‑term investors may prefer to wait for price stabilization.
Given the attractive dividend yield, solid cash generation, and defensive positioning, the stock appears fairly valued with a slight upside potential. The combination of stable earnings, dividend sustainability, and modest growth from new product lines supports a buy stance for medium‑ to long‑term horizons, while short‑term investors may prefer to wait for price stabilization.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below short‑term moving averages
- Bearish MACD histogram
- Stable volume with limited upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Record profit growth and strong operating margins
- Attractive dividend yield with sustainable payout
- Technical bullish trend despite short‑term pullback
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Defensive consumer‑staples sector with low beta
- Growth potential from reduced‑risk and pharmaceutical segments
- Consistent cash flow supporting dividend and debt servicing
Key Metrics & Analysis
Financial Health
Profit Margin14.71%
P/E Ratio20.4
ROE12.15%
ROA6.39%
Debt/Equity45.79
P/B Ratio2.5
Op. Cash Flow¥514.1B
Free Cash Flow¥181.6B
Technical Analysis
TrendBullish
RSI44.5
Support¥5,551.00
Resistance¥6,182.00
MA 20¥5,921.40
MA 50¥5,805.26
MA 200¥5,086.80
MACDBearish
VolumeStable
Fear & Greed Index79.57
Valuation
Fair Value¥931.31
Target Price¥6,115.00
Upside/Downside6.48%
GradeFair
TypeBlend
Dividend Yield4.28%
Risk Assessment
Beta0.06
Volatility22.25%
Sector RiskLow
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.